The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...
ADT speeds coronary atherosclerosis, with greater effects with use of the GnRH-agonist leuprolide compared with the GnRH-antagonist relugolix. Coronary atherosclerosis may progress more over 12 months ...
LUPRON DEPOT-3 MONTH 11.25mg prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.
*Localized: T 1/2, NX or N0, and M0. ‡ Locally advanced: T3/4, NX or N0, and M0, or N1 and M0. ITT: Intention to treat; PSA: Prostate-specific antigen. Reproduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback